An evolving web of signaling networks regulated by Cripto-1

Growth Factors

Volumn 30, Issue 1, 2012, Pages 13-21

  Nagaoka, Tadahiro ^a   Karasawa, Hideaki ^a   Castro, Nadia Pereira ^a   Rangel, Maria Cristina ^a   Salomon, David S ^a   Bianco, Caterina ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cripto 1; MAPK AKT signaling pathway; Nodal Cripto 1 dependent signaling pathway; Notch; Wnt catenin

Indexed keywords

ACTIVIN; APELIN; BETA CATENIN; CAVEOLIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR 4; GLUCOSE REGULATED PROTEIN 78; GLYPICAN 1; GROWTH DIFFERENTIATION FACTOR 1; GROWTH DIFFERENTIATION FACTOR 3; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; NOTCH RECEPTOR; PROTEIN CRIPTO 1; PROTEIN KINASE B; PROTEIN NODA1; PROTEIN TYROSINE KINASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; WNT PROTEIN;

ANGIOGENESIS; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; EMBRYO DEVELOPMENT; EPITHELIAL MESENCHYMAL TRANSITION; EUKARYOTIC CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; CRICETINAE; EMBRYONIC DEVELOPMENT; GENE EXPRESSION REGULATION; GPI-LINKED PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NEOPLASM PROTEINS; NEOPLASMS; SIGNAL TRANSDUCTION;

ANIMALIA; EUKARYOTA;

EID: 84855847198     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977194.2011.641962     Document Type: Article

References (67)

1. Adkins HB, Bianco C, Schiffer SG, Rayhorn P, Zafari M, Cheung AE, Orozco O, Olson D, De Luca A, Chen LL, Miatkowski K, Benjamin C, Normanno N, Williams KP, Jarpe M, LePage D, Salomon D, Sanicola M. 2003. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. J Clin Invest 112:575-587. (Pubitemid 38056342)
2. Andersson O, Bertolino P, Ibanez CF. 2007. Distinct and cooperative roles ofmammalian Vg1 homologsGDF1 andGDF3 during early embryonic development. Dev Biol 311:500-511. (Pubitemid 350046540)
3. Bianco C, Salomon DS. 2010.Targeting the embryonic gene Cripto- 1 in cancer and beyond. Expert Opin Ther Pat 20:1739-1749.
4. Bianco C, Kannan S, De Santis M, Seno M, Tang CK, Martinez- Lacaci I, Kim N, Wallace-Jones B, Lippman ME, Ebert AD, Wechselberger C, Salomon DS. 1999. Cripto-1 indirectly stimulates the tyrosine phosphorylation of erb B-4 through a novel receptor. J Biol Chem 274:8624-8629. (Pubitemid 29164656)
5. Bianco C, Adkins HB,Wechselberger C, Seno M, Normanno N, De Luca A, Sun Y, Khan N, Kenney N, Ebert A, Williams KP, Sanicola M, Salomon DS. 2002. Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial cells. Mol Cell Biol 22:2586-2597. (Pubitemid 34262981)
6. Bianco C, Strizzi L, Rehman A, Normanno N, Wechselberger C, Sun Y, Khan N, Hirota M, Adkins H, Williams K, Margolis RU, Sanicola M, Salomon DS. 2003. A Nodal- and ALK4- independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src. Cancer Res 63:1192-1197. (Pubitemid 36348694)
7. Bianco C, Strizzi L, Mancino M, Watanabe K, Gonzales M, Hamada S, Raafat A, Sahlah L, Chang C, Sotgia F, Normanno N, Lisanti M, Salomon DS. 2008. Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells. Am J Pathol 172:345-357. (Pubitemid 351282022)
8. Bianco C, RangelMC, CastroNP, NagaokaT, Rollman K, Gonzales M, Salomon DS. 2010. Role of Cripto-1 in stem cell maintenance and malignant progression. Am J Pathol 177:532-540.
9. Bikkavilli RK, Malbon CC. 2009. Mitogen-activated protein kinases and Wnt/beta-catenin signaling: Molecular conversations among signaling pathways. Commun Integr Biol 2:46-49.
10. Blanchet MH, Le Good JA, Mesnard D, Oorschot V, Baflast S, Minchiotti G, Klumperman J, Constam DB. 2008a. Cripto recruits Furin and PACE4 and controls Nodal trafficking during proteolytic maturation. EMBO J 27:2580-2591.
11. Blanchet MH, Le Good JA, Oorschot V, Baflast S, Minchiotti G, Klumperman J, Constam DB. 2008b. Cripto localizes Nodal at the limiting membrane of early endosomes. Sci Signal 1:ra13.
12. Calvanese L, Marasco D, Doti L, Saporito A, D'Auria G, Paolillo L, Ruvo M, Falcigno L. 2010. Structural investigation on the Nodal-Cripto binding: A theoretical and experimental approach. Biopolymers 93:1011-1021.
13. Carpene C, Dray C, Attane C, Valet P, Portillo MP, Churruca I, Milagro FI, Castan-Laurell I. 2007. Expanding role for the apelin/APJ system in physiopathology. J Physiol Biochem 63: 359-373.
14. Chen C, Shen MM. 2004. Two modes by which Lefty proteins inhibit nodal signaling. Curr Biol 14:618-624. (Pubitemid 38463593)
15. Chen C, Ware SM, Sato A, Houston-Hawkins DE, Habas R, Matzuk MM, Shen MM, Brown CW. 2006. The Vg1-related protein Gdf3 acts in a Nodal signaling pathway in the pregastrulation mouse embryo. Development 133:319-329. (Pubitemid 43210720)
16. Cheng SK, Olale F, Bennett JT, Brivanlou AH, Schier AF. 2003. EGF-CFC proteins are essential coreceptors for the TGF-beta signals Vg1 and GDF1. Genes Dev 17:31-36. (Pubitemid 36062505)
17. Chu J, Shen MM. 2010. Functional redundancy of EGF-CFC genes in epiblast and extraembryonic patterning during early mouse embryogenesis. Dev Biol 342:63-73.
18. Ciccodicola A, Dono R, Obici S, Simeone A, Zollo M, Persico MG. 1989. Molecular characterization of a gene of the 'EGF family' expressed in undifferentiated human NTERA2 teratocarcinoma cells. EMBO J 8:1987-1991. (Pubitemid 19273525)
19. Cocciadiferro L, Miceli V, Kang KS, Polito LM, Trosko JE, Carruba G. 2009. Profiling cancer stem cells in androgenresponsive and refractory human prostate tumor cell lines. Ann NY Acad Sci 1155:257-262.
20. Constam DB. 2009. Riding shotgun: A dual role for the epidermal growth factor-Cripto/FRL-1/Cryptic protein Cripto in Nodal trafficking. Traffic 10:783-791.
21. D'Andrea D, Liguori GL, Le Good JA, Lonardo E, Andersson O, Constam DB, Persico MG, Minchiotti G. 2008. Cripto promotes A-P axis specification independently of its stimulatory effect on Nodal autoinduction. J Cell Biol 180:597-605. (Pubitemid 351240706)
22. D'Aniello C, Lonardo E, Iaconis S, Guardiola O, Liguoro AM, Liguori GL, Autiero M, Carmeliet P, Minchiotti G. 2009. G protein-coupled receptor APJ and its ligand apelin act downstream of Cripto to specify embryonic stem cells toward the cardiac lineage through extracellular signal-regulated kinase/ p70S6 kinase signaling pathway. Circ Res 105:231-238.
23. de Castro NP, Rangel MC, Nagaoka T, Salomon DS, Bianco C. 2010. Cripto-1: An embryonic gene that promotes tumorigenesis. Future Oncol 6:1127-1142.
24. Ding JX, Yang L, YanYT, Chen A, DesaiN,Wynshaw-Boris A, Shen MM. 1998. Cripto is required for correct orientation of the anterior-posterior axis in themouse embryo.Nature 395:702-707. (Pubitemid 28475967)
25. Gray PC, Harrison CA, ValeW. 2003. Cripto forms a complex with activin and type II activin receptors and can block activin signaling. Proc Natl Acad Sci USA 100:5193-5198. (Pubitemid 36542681)
26. Gray PC, Shani G, Aung K, Kelber J, Vale W. 2006. Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGFbeta signaling. Mol Cell Biol 26:9268-9278. (Pubitemid 44904422)
27. Hamada S, Watanabe K, Hirota M, Bianco C, Strizzi L, Mancino M, Gonzales M, Salomon DS. 2007. Beta-catenin/TCF/LEF regulate expression of the short form human Cripto-1. Biochem Biophys Res Commun 355:240-244. (Pubitemid 46273393)
28. Harms PW, Chang C. 2003. Tomoregulin-1 (TMEFF1) inhibits nodal signaling through direct binding to the nodal coreceptor Cripto. Genes Dev 17:2624-2629. (Pubitemid 37363066)
29. Harrison H, Farnie G, Brennan KR, Clarke RB. 2010. Breast cancer stemcells: Something out ofnotching?CancerRes 70:8973-8976.
30. Hirota M, Watanabe K, Hamada S, Sun Y, Strizzi L, Mancino M, Nagaoka T, Gonzales M, Seno M, Bianco C, Salomon DS. 2008. Smad2 unctions as a co-activator of canonical Wnt/beta-catenin signaling pathway independent of Smad4 through histone acetyltransferase activity of p300. Cell Signal 20:1632-1641.
31. Hnasko R, Lisanti MP. 2003. The biology of caveolae: Lessons from caveolin knockout mice and implications for human disease. Mol Interv 3:445-464.
32. Hu T, Li C. 2010. Convergence between Wnt-beta-catenin and EGFR signaling in cancer. Mol Cancer 9:236.
33. Kelber JA, Shani G, Booker EC, Vale WW, Gray PC. 2008. Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal. J Biol Chem 283: 4490-4500.
34. Kelber JA, Panopoulos AD, Shani G, Booker EC, Belmonte JC, Vale WW, Gray PC. 2009. Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/ PI3K and Smad2/3 pathways. Oncogene 28:2324-2336.
35. Krebs LT, Iwai N, Nonaka S, Welsh IC, Lan Y, Jiang R, Saijoh Y, O'Brien TP, Hamada H, Gridley T. 2003. Notch signaling regulates left-right asymmetry determination by inducing Nodal expression. Genes Dev 17:1207-1212. (Pubitemid 36583163)
36. Liguori GL, Borges AC, D'Andrea D, Liguoro A, Goncalves L, Salgueiro AM, Persico MG, Belo JA. 2008. Cripto-independent Nodal signaling promotes positioning of the A-P axis in the early mouse embryo. Dev Biol 15:280-289.
37. Meno C, Ito Y, Saijoh Y, Matsuda Y, Tashiro K, Kuhara S, Hamada H. 1997. Two closely-related left-right asymmetrically expressed genes, lefty-1 and lefty-2: Their distinct expression domains, chromosomal linkage and direct neuralizing activity in Xenopus embryos. Genes Cells 2:513-524. (Pubitemid 127688599)
38. Miharada K, Karlsson G, Rehn M, Rorby E, Siva K, Cammenga J, Karlsson S. 2011. Cripto regulates hematopoietic stem cells as a hypoxic-niche-related factor through cell surface GRP78. Cell Stem Cell 9:330-344.
39. Minchiotti G, Manco G, Parisi S, Lago CT, Rosa F, Persico MG. 2001. Structure-function analysis of the EGF-CFC family member Cripto identifies residues essential for nodal signalling. Development 128:4501-4510. (Pubitemid 33130430)
40. Morkel M, Huelsken J, Wakamiya M, Ding J, van de Wetering M, Clevers H, Taketo MM, Behringer RR, Shen MM, Birchmeier W. 2003. Beta-catenin regulates Cripto- and Wnt3-dependent gene expression programs in mouse axis and mesoderm formation. Development 130:6283-6294. (Pubitemid 38008826)
41. Ni M, Zhang Y, Lee AS. 2011. Beyond the endoplasmic reticulum: Atypical GRP78 in cell viability, signalling and therapeutic targeting. Biochem J 434:181-188.
42. Nusse R, Fuerer C, Ching W, Harnish K, Logan C, Zeng A, ten Berge D, Kalani Y. 2008. Wnt signaling and stem cell control. Cold Spring Harb Symp Quant Biol 73:59-66.
43. Postovit LM, Seftor EA, Seftor RE, Hendrix MJ. 2007. Targeting Nodal in malignant melanoma cells. Expert Opin Ther Targets 11:497-505. (Pubitemid 46487597)
44. Qiao M, Sheng S, Pardee AB. 2008. Metastasis and AKTactivation. Cell Cycle 7:2991-2996.
45. Quest AF, Leyton L, Parraga M. 2004. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease. Biochem Cell Biol 82:129-144. (Pubitemid 38580879)
46. Raya A, Kawakami Y, Rodriguez-Esteban C, Buscher D, Koth CM, Itoh T, Morita M, Raya RM, Dubova I, Bessa JG, de la Pompa JL, Izpisua Belmonte JC. 2003. Notch activity induces Nodal expression and mediates the establishment of left-right asymmetry in vertebrate embryos. Genes Dev 17:1213-1218. (Pubitemid 36583164)
47. Reissmann E, Jornvall H, Blokzijl A, Andersson O, Chang C, Minchiotti G, Persico MG, Ibanez CF, Brivanlou AH. 2001. The orphan receptor ALK7 and the activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development. Genes Dev 15:2010-2022. (Pubitemid 32738629)
48. Reya T, Clevers H. 2005. Wnt signalling in stem cells and cancer. Nature 434:843-850. (Pubitemid 40558990)
49. Sato M, Yao VJ, ArapW, Pasqualini R. 2010. GRP78 signaling hub: A receptor for targeted tumor therapy. Adv Genet 69:97-114.
50. Schier AF. 2003. Nodal signaling in vertebrate development. Annu Rev Cell Dev Biol 19:589-621. (Pubitemid 37487362)
51. Shani G, Fischer WH, Justice NJ, Kelber JA, Vale W, Gray PC. 2008. GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor beta signaling and enhance cell growth. Mol Cell Biol 28:666-677.
52. Srinivasan R, Gillett CE, Barnes DM, Gullick WJ. 2000. Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers. Cancer Res 60:1483-1487. (Pubitemid 30183410)
53. Strizzi L, Abbott DE, Salomon DS, Hendrix MJ. 2008. Potential for cripto-1 in defining stem cell-like characteristics in human malignant melanoma. Cell Cycle 7:1931-1935. (Pubitemid 352030336)
54. Tanegashima K, Haramoto Y, Yokota C, Takahashi S, AsashimaM. 2004. Xantivin suppresses the activity of EGF-CFC genes to regulate nodal signaling. Int J Dev Biol 48:275-283. (Pubitemid 38917757)
55. Tao Q, Yokota C, Puck H, Kofron M, Birsoy B, YanD, Asashima M, Wylie CC, Lin X, Heasman J. 2005. Maternal wnt11 activates the canonical wnt signaling pathway required for axis formation in Xenopus embryos. Cell 120:857-871. (Pubitemid 40575651)
56. Uchida T, Wada K, Akamatsu T, Yonezawa M, Noguchi H, Mizoguchi A, Kasuga M, Sakamoto C. 1999. A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells. Biochem Biophys Res Commun 266:593-602. (Pubitemid 30028713)
57. Wang Z, Li Y, Banerjee S, Sarkar FH. 2009. Emerging role of Notch in stem cells and cancer. Cancer Lett 279:8-12.
58. Watanabe K, Bianco C, Strizzi L, Hamada S, Mancino M, Bailly V, Mo W, Wen D, Miatkowski K, Gonzales M, Sanicola M, Seno M, Salomon DS. 2007a. Growth factor induction of Cripto-1 shedding by glycosylphosphatidylinositol- phospholipase D and enhancement of endothelial cell migration. J Biol Chem 282: 31643-31655. (Pubitemid 350044849)
59. Watanabe K, Hamada S, Bianco C, Mancino M, Nagaoka T, Gonzales M, Bailly V, Strizzi L, Salomon DS. 2007b. Requirement of glycosylphosphatidylinositol anchor of cripto-1 for 'trans' activity as a nodal co-receptor. J Biol Chem 289: 35772-35786. (Pubitemid 350277152)
60. Watanabe K, Nagaoka T, Lee JM, Bianco C, Gonzales M, Castro NP, Rangel MC, Sakamoto K, Sun Y, Callahan R, Salomon DS. 2009. Enhancement of Notch receptor maturation and signaling sensitivity by Cripto-1. J Cell Biol 187:343-353.
61. Watanabe K, Meyer MJ, Strizzi L, Lee JM, Gonzales M, Bianco C, Nagaoka T, Farid SS, Margaryan N, Hendrix MJ, Vonderhaar BK, Salomon DS. 2010. Cripto-1 is a cell surface marker for a tumorigenic, undifferentiated subpopulation in human embryonal carcinoma cells. Stem Cells 28:1303-1314.
62. Williams TM, Lisanti MP. 2005. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 288:C494-C506. (Pubitemid 40229478)
63. Xu C, Liguori G, Persico MG, Adamson ED. 1999a. Abrogation of the Cripto gene in mouse leads to failure of postgastrulation morphogenesis and lack of differentiation of cardiomyocytes. Development 126:483-494. (Pubitemid 29082035)
64. Xu CH, Liguori G, Persico MG, Adamson ED. 1999b. Abrogation of the Cripto gene in mouse leads to failure of postgastrulation morphogenesis and lack of differentiation of cardiomyocytes. Development 126:483-494. (Pubitemid 29082035)
65. Yan YT, Liu JJ, Luo Y, E C, Haltiwanger RS, Abate-Shen C, Shen MM. 2002. Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway. Mol Cell Biol 22:4439-4449. (Pubitemid 34620383)
66. Yeo C, Whitman M. 2001. Nodal signals to Smads through Criptodependent and Cripto-independent mechanisms. Mol Cell 7: 949-957. (Pubitemid 32525742)
67. Yin L, Velazquez OC, Liu ZJ. 2010. Notch signaling: Emerging molecular targets for cancer therapy. Biochem Pharmacol 80: 690-701.